BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abikhair M, Mitsui H, Yanofsky V, Roudiani N, Ovits C, Bryan T, Oberyszyn TM, Tober KL, Gonzalez J, Krueger JG, Felsen D, Carucci JA. Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22. JCI Insight 2016;1:e86434. [PMID: 27699266 DOI: 10.1172/jci.insight.86434] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Dang N, Waer M, Sprangers B, Lin Y. Establishment of operational tolerance to sustain antitumor immunotherapy. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.01.019] [Reference Citation Analysis]
2 Janikowska G, Kurzeja E, Janikowski M, Strzałka-Mrozik B, Pyka-Pająk A, Janikowski T. The Effect of Cyclosporine A on Dermal Fibroblast Cell - Transcriptomic Analysis of Inflammatory Response Pathway. Curr Pharm Biotechnol 2020;21:1213-23. [PMID: 32297577 DOI: 10.2174/1389201021666200416103928] [Reference Citation Analysis]
3 Corchado-Cobos R, García-Sancha N, González-Sarmiento R, Pérez-Losada J, Cañueto J. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy. Int J Mol Sci 2020;21:E2956. [PMID: 32331425 DOI: 10.3390/ijms21082956] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
4 Hart PH, Norval M. Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis. Photochem Photobiol Sci 2018;17:1872-84. [PMID: 29136080 DOI: 10.1039/c7pp00312a] [Cited by in Crossref: 40] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
5 Morciano G, Preti D, Pedriali G, Aquila G, Missiroli S, Fantinati A, Caroccia N, Pacifico S, Bonora M, Talarico A, Morganti C, Rizzo P, Ferrari R, Wieckowski MR, Campo G, Giorgi C, Trapella C, Pinton P. Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F 1 /F O -Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction. J Med Chem 2018;61:7131-43. [DOI: 10.1021/acs.jmedchem.8b00278] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
6 Pradhan J, Mohanty C, Sahoo SK. Protective efficacy of crocetin and its nanoformulation against cyclosporine A-mediated toxicity in human embryonic kidney cells. Life Sci 2019;216:39-48. [PMID: 30444987 DOI: 10.1016/j.lfs.2018.11.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Arshad T, Mansur F, Palek R, Manzoor S, Liska V. A Double Edged Sword Role of Interleukin-22 in Wound Healing and Tissue Regeneration. Front Immunol 2020;11:2148. [PMID: 33042126 DOI: 10.3389/fimmu.2020.02148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Morciano G, Naumova N, Koprowski P, Valente S, Sardão VA, Potes Y, Rimessi A, Wieckowski MR, Oliveira PJ. The mitochondrial permeability transition pore: an evolving concept critical for cell life and death. Biol Rev Camb Philos Soc 2021. [PMID: 34155777 DOI: 10.1111/brv.12764] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Marzejon M, Kosowska M, Majchrowicz D, Bułło-Piontecka B, Wąsowicz M, Jędrzejewska-Szczerska M. Optical-Spectrometry-Based Method for Immunosuppressant Medicine Level Detection in Aqueous Solutions. Sensors (Basel) 2018;18:E2001. [PMID: 29932121 DOI: 10.3390/s18072001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Chen A, Santana AL, Doudican N, Roudiani N, Laursen K, Therrien JP, Lee J, Felsen D, Carucci JA. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS One 2020;15:e0241551. [PMID: 33227008 DOI: 10.1371/journal.pone.0241551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pangavhane S, Makrlík E, Ruzza P, Kašička V. Affinity capillary electrophoresis employed for determination of stability constants of antamanide complexes with univalent and divalent cations in methanol. ELECTROPHORESIS 2019. [DOI: 10.1002/elps.201900043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Abikhair Burgo M, Roudiani N, Chen J, Santana AL, Doudican N, Proby C, Felsen D, Carucci JA. Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma. JCI Insight 2018;3:120750. [PMID: 30185657 DOI: 10.1172/jci.insight.120750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
13 Čeović R, Petković M, Mokos ZB, Kostović K. Nonsurgical treatment of nonmelanoma skin cancer in the mature patient. Clinics in Dermatology 2018;36:177-87. [DOI: 10.1016/j.clindermatol.2017.10.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang Y, Liu C, Gao J, Shao S, Cui Y, Yin S, Pan B. IL-22 promotes tumor growth of breast cancer cells in mice. Aging (Albany NY) 2020;12:13354-64. [PMID: 32649314 DOI: 10.18632/aging.103439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Frazzette N, Khodadadi-Jamayran A, Doudican N, Santana A, Felsen D, Pavlick AC, Tsirigos A, Carucci JA. Decreased cytotoxic T cells and TCR clonality in organ transplant recipients with squamous cell carcinoma. NPJ Precis Oncol 2020;4:13. [PMID: 32550269 DOI: 10.1038/s41698-020-0119-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Salomaa T, Pemmari T, Määttä J, Kummola L, Salonen N, González-Rodríguez M, Parviainen L, Hiihtola L, Vähätupa M, Järvinen TAH, Junttila IS. IL-13Rα1 Suppresses Tumor Progression in Two-stage Skin Carcinogenesis Model by Regulating Regulatory T Cells. J Invest Dermatol 2021:S0022-202X(21)02525-2. [PMID: 34808240 DOI: 10.1016/j.jid.2021.11.013] [Reference Citation Analysis]
17 Lewis JM, Monico PF, Mirza FN, Xu S, Yumeen S, Turban JL, Galan A, Girardi M. Chronic UV radiation-induced RORγt+ IL-22-producing lymphoid cells are associated with mutant KC clonal expansion. Proc Natl Acad Sci U S A 2021;118:e2016963118. [PMID: 34504008 DOI: 10.1073/pnas.2016963118] [Reference Citation Analysis]
18 Santana AL, Felsen D, Carucci JA. Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma. Dermatol Clin. 2017;35:73-84. [PMID: 27890239 DOI: 10.1016/j.det.2016.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
19 Arbiser JL, Bonner MY, Ward N, Elsey J, Rao S. Selenium unmasks protective iron armor: A possible defense against cutaneous inflammation and cancer. Biochim Biophys Acta Gen Subj 2018;1862:2518-27. [PMID: 29852199 DOI: 10.1016/j.bbagen.2018.05.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
20 Eigentler TK, Leiter U, Häfner H, Garbe C, Röcken M, Breuninger H. Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study. Journal of Investigative Dermatology 2017;137:2309-15. [DOI: 10.1016/j.jid.2017.06.025] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 10.6] [Reference Citation Analysis]
21 Ume AC, Pugh JM, Kemp MG, Williams CR. Calcineurin inhibitor (CNI)‐associated skin cancers: New insights on exploring mechanisms by which CNIs downregulate DNA repair machinery. Photodermatol Photoimmunol Photomed 2020;36:433-40. [DOI: 10.1111/phpp.12600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Grabarek BO, Wcisło-Dziadecka D, Michalska-Bańkowska A, Gola J. Evaluation of expression pattern of selected genes associated with IL12/23 signaling paths in psoriatic patients during cyclosporine A therapy. Dermatol Ther 2019;32:e13129. [PMID: 31631469 DOI: 10.1111/dth.13129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]